News

Online information system hits milestone

Male and female drug use: is the gap narrowing?

Gender differences in patterns of drug use are addressed today by the EU drugs agency (EMCDDA) in a technical paper marking International Women’s Day. According to the paper, men in the EU...

Illicit drug use in the EU: legislative approaches

Co-morbidity: drug use and mental disorders

Between 50% and 90% of drug users are reported to suffer from personality disorders and around one-fifth (15–20%) from more serious psychotic complaints. Yet mental disorders related to addiction are far less...

Overdose: a major cause of avoidable death among young people

Hepatitis C and injecting drug use: impact, costs and policy options

2004 Annual report: 'Selected issues'

2004 Annual report: 10 years of reporting

2004 Annual report: highlights

2004 Annual report from the EU drugs agency

Evaluation of the EU strategy and action plan on drugs (2000 –2004)

Evaluation of the EU strategy and action plan on drugs (2000-2004)

New feature on ELDD offers easy access to EU drug legislation

New online pool of national drug information

Drug treatment now more available, accessible and diverse

New EMCDDA study asks ‘Is cannabis getting stronger?’

The way forward for EU action against drugs

Russian delegation visits EU drugs agency

Upcoming changes at EU drugs agency

Hepatitis C — the 'hidden epidemic'

‘A hidden epidemic’ and ‘a major challenge to public health’ – this is how the EU drugs agency, the Lisbon-based EMCDDA, describes hepatitis C in the latest edition of its Drugs in...